A lackluster earnings announcement from Bunge Global SA (NYSE:BG) last week didn't sink the stock price. We think that investors are worried about some weaknesses underlying the earnings. Our free ...

Bunge Global SA saw profits shrink in the first quarter, adding to the list of crop merchants hit by mounting uncertainty over US trade and biofuel policies. Earnings excluding some items were $1. ...

Bunge Q1 EPS came in at $1.81, topping estimates, as tariff-driven demand shifts offset a 13% drop in sales. The company reaffirmed its 2025 EPS forecast of ~$7.75 and is nearing closure of the ...

Bunge’s margarines & spreads activities in Europe represent a turnover of more than €450m ($486.9m).

The merger between Bunge and Viterra would Increase Bunge's revenues by approximately 100%. Read why I upgrade BG stock from sell to buy.

Photo by KAYLE NEIS / Regina Leader-Post The federal government’s approval of Bunge Global SA’s $8.2-billion acquisition of Viterra Inc. is drawing mixed reactions from farming groups.

As part of the approval, Bunge will need to sell six grain elevators in Western Canada, as well as commit to investing at least $520 million in Canada within the next five years. Photo by John ...

Bunge’s forward price-to-earnings ratio is at X13.61 against the industry average of 19.52. This gives off a difference of -30.28% indicating the company is undervalued with a significant upside ...

The Competition Bureau raised a red flag over Bunge’s 25 per cent stake in G3 Global Holdings, a joint venture with a Saudi firm that operates grain facilities in Canada and is a major competitor to ...

Mary Bartlett Bunge, who with her husband, Richard, studied how the body responds to spinal cord injuries and continued their work after his death in 1996, ultimately discovering a promising ...